News
Oncolytics Biotech Reports Submission Of A Type C Meeting Request To FDA
11 Apr 24
News, FDA
Raymond James Initiates Coverage On Oncolytics Biotech with Outperform Rating, Announces Price Target of $3
4 Apr 24
News, Price Target, Initiation, Analyst Ratings
HC Wainwright & Co. Maintains Buy on Oncolytics Biotech, Maintains $5 Price Target
8 Mar 24
News, Price Target, Analyst Ratings
Recap: Oncolytics Biotech Q4 Earnings
7 Mar 24
Earnings
Earnings Scheduled For March 7, 2024
7 Mar 24
Earnings
A Preview Of Oncolytics Biotech's Earnings
6 Mar 24
Earnings
HC Wainwright & Co. Reiterates Buy on Oncolytics Biotech, Maintains $5 Price Target
14 Feb 24
News, Price Target, Reiteration, Analyst Ratings
Press releases
Biotech Innovations Paving the Way in Breast Cancer Fight
11 Apr 24
Small Cap, Opinion, Press Releases
Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA
11 Apr 24
Small Cap, Press Releases
Oncolytics Biotech® to Participate in a Panel Presentation at Canaccord Genuity's Horizons in Oncology Virtual Conference
2 Apr 24
Small Cap, Press Releases
Biotech's Role in Addressing the Pancreatic Cancer Emergency
14 Mar 24
Small Cap, Opinion, Press Releases
Oncolytics Biotech® Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
7 Mar 24
Earnings, Small Cap, Press Releases
Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments
5 Mar 24
Biotech, Press Releases, General
Oncolytics Biotech® Files Amendment to Initiate New Pancreatic Cancer GOBLET Cohort Supported by PanCAN
5 Mar 24
Small Cap, Press Releases
Oncolytics Biotech® to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results and Recent Operational Highlights
4 Mar 24
Earnings, Small Cap, Press Releases
Oncolytics Biotech® Announces Presentation at the Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer Conference
28 Feb 24
Press Releases
Anal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focus on New Therapies
14 Feb 24
Biotech, Press Releases, General
Oncolytics Biotech® Initiates Enrollment Expansion of GOBLET Anal Cancer Cohort
14 Feb 24
Small Cap, Press Releases
Pancreatic Cancer Treatments Poised for Major Advances in 2024
7 Feb 24
Small Cap, Opinion, Press Releases